Kura Oncology Inc. Insider Trading

KURA

Last 12 months

Insiders bought $2.35M and sold $3.84M on the open market.

50% of the selling was scheduled in advance under 10b5-1 plans. Chief Medical Officer Mollie Leoni sold 440K on Sep 29, 23% of their stake, outside a plan.

Net open-market

−$1.49M

2 buys · 26 sales

Under a 10b5-1 plan

50%

of the value sold

Insiders who bought / sold

1 / 7

executives and directors

Last open-market buy

Aug 2026

Aug 24, 2026

Get an email when KURA's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Sep 28 – 29	Kathleen Ford Chief Operating Officer	Sold10b5-1 plan 2 parts	10,574	$10.59 average	112K	6.9%	Form 4
Sep 28 – 29	Mollie Leoni Chief Medical Officer	SoldNo plan 2 parts	41,250	$10.67 average	440K	23%	Form 4
Sep 28 – 29	Brian T. Powl Chief Commercial Officer	SoldNo plan 3 parts	32,450	$10.63 average	345K	19%	Form 4
Sep 28	Teresa Brophy Bair Chief Legal Officer	Sold10b5-1 plan	8,442	$10.50	89K	4.3%	Form 4
Sep 28	Thomas James Doyle SVP, Finance & Accounting	SoldNo plan	4,607	$10.50	48K	3.1%	Form 4
Sep 24	Francis Burrows Chief Scientific Officer	SoldNo plan	20,726	$10.83	224K	33%	Form 4
Aug 24	Troy Edward Wilson President and CEO	Bought	100,000	$12.39	$1.24M	9.0%	Form 4
Aug 21	Brian T. Powl Chief Commercial Officer	Sold10b5-1 plan	4,345	$11.89	52K	2.5%	Form 4
Aug 19	Teresa Brophy Bair Chief Legal Officer	Sold10b5-1 plan	31,487	$12.63	398K	14%	Form 4
Aug 17	Troy Edward Wilson President and CEO	Bought	100,000	$11.12	$1.11M	9.9%	Form 4
Jun 18	Mollie Leoni Chief Medical Officer	Sold10b5-1 plan	84,929	$9.82	834K	32%	Form 4
May 21	Brian T. Powl Chief Commercial Officer	Sold10b5-1 plan	10,000	$11.00	110K	5.4%	Form 4
May 19	Kathleen Ford Chief Operating Officer	Sold10b5-1 plan	2,257	$9.08	20K	1.4%	Form 4
May 19	Brian T. Powl Chief Commercial Officer	Sold10b5-1 plan	339	$9.21	3K	0.2%	Form 4
May 18	Teresa Brophy Bair Chief Legal Officer	Sold10b5-1 plan	2,256	$9.38	21K	1.0%	Form 4
Jan 27	Francis Burrows Chief Scientific Officer	SoldNo plan	1,311	$8.46	11K	3.9%	Form 4
Jan 27	Brian T. Powl Chief Commercial Officer	SoldNo plan 2 parts	6,414	$8.46 average	54K	3.4%	Form 4
Jan 27	Kathleen Ford Chief Operating Officer	SoldNo plan	1,813	$8.46	15K	1.2%	Form 4
Jan 27	Mollie Leoni Chief Medical Officer	SoldNo plan 4 parts	8,180	$8.46 average	69K	3.0%	Form 4
Jan 27	Thomas James Doyle SVP, Finance & Accounting	SoldNo plan 5 parts	7,142	$8.46 average	60K	4.7%	Form 4
Jan 27	Teresa Brophy Bair Chief Legal Officer	SoldNo plan 3 parts	11,208	$8.46 average	95K	4.7%	Form 4
Dec 18, 2025	Francis Burrows Chief Scientific Officer	SoldNo plan	23,726	$9.78	232K	41%	Form 4
Dec 9, 2025	Faheem Hasnain Director	Sold10b5-1 plan	10,000	$10.98	110K	29%	Form 4
Nov 14, 2025	Teresa Brophy Bair Chief Legal Officer	Sold10b5-1 plan	8,804	$11.18	98K	4.5%	Form 4
Nov 14, 2025	Brian T. Powl Chief Commercial Officer	SoldNo plan	8,887	$11.18	99K	6.0%	Form 4
Nov 14, 2025	Mollie Leoni Chief Medical Officer	SoldNo plan	15,485	$11.18	173K	6.4%	Form 4
Nov 14, 2025	Thomas James Doyle SVP, Finance & Accounting	SoldNo plan	4,539	$11.18	51K	3.4%	Form 4
Nov 14, 2025	Kathleen Ford Chief Operating Officer	Sold10b5-1 plan	6,902	$11.18	77K	6.1%	Form 4
Sep 29, 2025	Brian T. Powl Chief Commercial Officer	SoldNo plan	8,891	$8.94	79K	8.2%	Form 4
Sep 29, 2025	Teresa Brophy Bair Chief Legal Officer	Sold10b5-1 plan	8,805	$8.94	79K	5.6%	Form 4
Sep 29, 2025	Kathleen Ford Chief Operating Officer	Sold10b5-1 plan	6,892	$8.94	62K	9.8%	Form 4
Sep 29, 2025	Mollie Leoni Chief Medical Officer	SoldNo plan	12,314	$8.94	110K	7.2%	Form 4
Sep 29, 2025	Troy Edward Wilson President and CEO	SoldNo plan	36,615	$8.94	327K	4.2%	Form 4
Sep 29, 2025	Thomas James Doyle SVP, Finance & Accounting	SoldNo plan	4,541	$8.94	41K	4.0%	Form 4
Sep 8, 2025	Troy Edward Wilson President & CEO	Bought	50,000	$8.20	410K	7.9%	Form 4
Aug 12, 2025 – Aug 13, 2025	Troy Edward Wilson President and CEO	Bought 2 parts	50,000	$6.06 average	303K	8.6%	Form 4
May 19, 2025	Teresa Brophy Bair Chief Legal Officer	Sold10b5-1 plan	1,559	$5.96	9K	1.4%	Form 4
May 19, 2025	Kathleen Ford Chief Operating Officer	Sold10b5-1 plan	1,558	$6.28	10K	6.8%	Form 4
Mar 21, 2025	Faheem Hasnain Director	Sold10b5-1 plan	22,682	$8.00	181K	49%	Form 4
Jan 28, 2025	Thomas James Doyle SVP, Finance & Accounting	SoldNo plan 4 parts	4,949	$7.87 average	39K	5.3%	Form 4

Sep 28 – 2910b5-1 plan
Kathleen Ford
Chief Operating Officer · sold 10,574 at avg $10.59
112K
6.9% of stake
Sep 28 – 29No plan
Mollie Leoni
Chief Medical Officer · sold 41,250 at avg $10.67
440K
23% of stake
Sep 28 – 29No plan
Brian T. Powl
Chief Commercial Officer · sold 32,450 at avg $10.63
345K
19% of stake
Sep 2810b5-1 plan
Teresa Brophy Bair
Chief Legal Officer · sold 8,442 at $10.50
89K
4.3% of stake
Sep 28No plan
Thomas James Doyle
SVP, Finance & Accounting · sold 4,607 at $10.50
48K
3.1% of stake
Sep 24No plan
Francis Burrows
Chief Scientific Officer · sold 20,726 at $10.83
224K
33% of stake
Aug 24
Troy Edward Wilson
President and CEO · bought 100,000 at $12.39
$1.24M
9.0% of stake
Aug 2110b5-1 plan
Brian T. Powl
Chief Commercial Officer · sold 4,345 at $11.89
52K
2.5% of stake
Aug 1910b5-1 plan
Teresa Brophy Bair
Chief Legal Officer · sold 31,487 at $12.63
398K
14% of stake
Aug 17
Troy Edward Wilson
President and CEO · bought 100,000 at $11.12
$1.11M
9.9% of stake
Jun 1810b5-1 plan
Mollie Leoni
Chief Medical Officer · sold 84,929 at $9.82
834K
32% of stake
May 2110b5-1 plan
Brian T. Powl
Chief Commercial Officer · sold 10,000 at $11.00
110K
5.4% of stake
May 1910b5-1 plan
Kathleen Ford
Chief Operating Officer · sold 2,257 at $9.08
20K
1.4% of stake
May 1910b5-1 plan
Brian T. Powl
Chief Commercial Officer · sold 339 at $9.21
3K
0.2% of stake
May 1810b5-1 plan
Teresa Brophy Bair
Chief Legal Officer · sold 2,256 at $9.38
21K
1.0% of stake
Jan 27No plan
Francis Burrows
Chief Scientific Officer · sold 1,311 at $8.46
11K
3.9% of stake
Jan 27No plan
Brian T. Powl
Chief Commercial Officer · sold 6,414 at avg $8.46
54K
3.4% of stake
Jan 27No plan
Kathleen Ford
Chief Operating Officer · sold 1,813 at $8.46
15K
1.2% of stake
Jan 27No plan
Mollie Leoni
Chief Medical Officer · sold 8,180 at avg $8.46
69K
3.0% of stake
Jan 27No plan
Thomas James Doyle
SVP, Finance & Accounting · sold 7,142 at avg $8.46
60K
4.7% of stake
Jan 27No plan
Teresa Brophy Bair
Chief Legal Officer · sold 11,208 at avg $8.46
95K
4.7% of stake
Dec 18, 2025No plan
Francis Burrows
Chief Scientific Officer · sold 23,726 at $9.78
232K
41% of stake
Dec 9, 202510b5-1 plan
Faheem Hasnain
Director · sold 10,000 at $10.98
110K
29% of stake
Nov 14, 202510b5-1 plan
Teresa Brophy Bair
Chief Legal Officer · sold 8,804 at $11.18
98K
4.5% of stake
Nov 14, 2025No plan
Brian T. Powl
Chief Commercial Officer · sold 8,887 at $11.18
99K
6.0% of stake
Nov 14, 2025No plan
Mollie Leoni
Chief Medical Officer · sold 15,485 at $11.18
173K
6.4% of stake
Nov 14, 2025No plan
Thomas James Doyle
SVP, Finance & Accounting · sold 4,539 at $11.18
51K
3.4% of stake
Nov 14, 202510b5-1 plan
Kathleen Ford
Chief Operating Officer · sold 6,902 at $11.18
77K
6.1% of stake
Sep 29, 2025No plan
Brian T. Powl
Chief Commercial Officer · sold 8,891 at $8.94
79K
8.2% of stake
Sep 29, 202510b5-1 plan
Teresa Brophy Bair
Chief Legal Officer · sold 8,805 at $8.94
79K
5.6% of stake
Sep 29, 202510b5-1 plan
Kathleen Ford
Chief Operating Officer · sold 6,892 at $8.94
62K
9.8% of stake
Sep 29, 2025No plan
Mollie Leoni
Chief Medical Officer · sold 12,314 at $8.94
110K
7.2% of stake
Sep 29, 2025No plan
Troy Edward Wilson
President and CEO · sold 36,615 at $8.94
327K
4.2% of stake
Sep 29, 2025No plan
Thomas James Doyle
SVP, Finance & Accounting · sold 4,541 at $8.94
41K
4.0% of stake
Sep 8, 2025
Troy Edward Wilson
President & CEO · bought 50,000 at $8.20
410K
7.9% of stake
Aug 12, 2025 – Aug 13, 2025
Troy Edward Wilson
President and CEO · bought 50,000 at avg $6.06
303K
8.6% of stake
May 19, 202510b5-1 plan
Teresa Brophy Bair
Chief Legal Officer · sold 1,559 at $5.96
9K
1.4% of stake
May 19, 202510b5-1 plan
Kathleen Ford
Chief Operating Officer · sold 1,558 at $6.28
10K
6.8% of stake
Mar 21, 202510b5-1 plan
Faheem Hasnain
Director · sold 22,682 at $8.00
181K
49% of stake
Jan 28, 2025No plan
Thomas James Doyle
SVP, Finance & Accounting · sold 4,949 at avg $7.87
39K
5.3% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch KURA, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with KURA

CompareIntrinsic value

ADCTADC Therapeutics S.A.

$1.72+10.97%10

ASMBAssembly Biosciences Inc.

$19.87-0.25%19

OMEROmeros Corporation

$18.18-0.49%27

VRDNViridian Therapeutics Inc.

$29.06+15.53%40

LABStandard Biotools Inc.

$0.62+1.38%35

RMTIRockwell Medical, Inc.

$8.05-0.49%37

FBIOFortress Biotech Inc.

$1.97+1.55%59

DERMJourney Medical Corp

$4.73+1.94%25

Held by ETFs

KURA is in 34 US ETFs. The largest of them, with KURA's weight in each:

Spot a number that looks wrong? Check it in KURA's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing KURA

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.